BAJAJ BROKING

Notification
No new Notification messages
Laxmi Dental IPO is Open!
Apply for the Laxmi Dental IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Sai Life Sciences IPO: Things Smart Investors Need to Know

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Overview of the Company

Incorporated in January 1999, Sai Life Sciences Limited is a global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in small-molecule new chemical entities (NCE). With over two decades of experience, the company provides tailored services to global biotech and pharmaceutical companies, including 18 of the top 25 pharma firms worldwide.

Core Business and Market Position


The company operates across the CRDMO value chain, offering discovery, development, and manufacturing solutions. With an experienced scientific team and operations spanning the US, UK, Europe, and Japan, Sai Life Sciences is positioned as an integrated healthcare innovator. For more details, visit the Sai Life Sciences IPO page.

Sai Life Sciences IPO Details and Objectives

Details

Specifications

IPO Date

December 11, 2024 - December 13, 2024

Issue Size

₹3,042.62 crore

Price Band

₹522 - ₹549 per share

Face Value

₹1 per share

Lot Size

27 shares

Fresh Issue

₹950 crore

Offer for Sale

₹2,092.62 crore

Listing At

BSE, NSE

Purpose of the IPO

  • Debt Reduction: Utilize proceeds for repayment or prepayment of borrowings.
  • General Corporate Purposes: Strengthen overall financial and operational capabilities.

Timeline of Sai Life Sciences IPO

Event

Date

IPO Opening Date

December 11, 2024

IPO Closing Date

December 13, 2024

Allotment Finalization

December 16, 2024

Refund Initiation

December 17, 2024

Credit of Shares

December 17, 2024

Listing Date

December 18, 2024

Pricing & Lot Size of Sai Life Sciences IPO

Price Band for the IPO

  • ₹522 to ₹549 per share.

Minimum Lot Size and Application Details

  • Retail Minimum Investment: ₹14,823 for 27 shares.
  • S-HNI Minimum Investment: ₹207,522 for 378 shares (14 lots).
  • B-HNI Minimum Investment: ₹1,007,964 for 1,836 shares (68 lots).

How to Apply for the Sai Life Sciences IPO?

Online Application Process

  • Log in to Your Trading Platform: Access your Bajaj Broking trading account.
  • Navigate to the IPO Section: Click on the "IPO" tab to view available IPOs.
  • Select the Sai Life Sciences IPO: Find the IPO and click "Apply."
  • Enter Application Details: Specify the number of shares and set the bid price within the price band.
  • Provide UPI ID: Enter your UPI ID to authorize payment.
  • Confirm Application: Review and submit your application.
  • Approve UPI Mandate: Approve the payment request before the deadline.

Financial Health and Performance

Key Financial Metrics

  • Revenue Growth: Increased from ₹1,245.11 crore (FY23) to ₹1,494.27 crore (FY24).
  • PAT Growth: Rose from ₹9.99 crore (FY23) to ₹82.81 crore (FY24), reflecting a 729% growth.
  • Assets: Grew from ₹2,186.65 crore (FY23) to ₹2,476.78 crore (FY24).

Recent Performance and Growth Prospects

  • Sustained growth in CRDMO and NCE services across global markets.
  • Continued investment in scientific talent and infrastructure.

H2: Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • Dependency on global pharma companies and economic conditions.
  • Competitive pressures in the CRO and CDMO sectors.
  • Potential pricing risks due to aggressive valuation metrics.

Opportunities and Growth Potential

  • Increasing global demand for CRDMO and NCE services.
  • Expansion into high-value pharma markets, including Japan and Europe.
  • Strong client portfolio with established global partnerships.

Key Performance Indicator (KPI)

KPI

Value

ROE

11.79%

ROCE

15.96%

RoNW

8.13%

P/BV

10.18

PAT Margin

5.65%

Sai Life Sciences IPO Registrar & Lead Managers

Role

Details

Registrar

Kfin Technologies Limited

Lead Managers

Kotak Mahindra Capital, Jefferies India, Morgan Stanley India, IIFL Securities

Company Address of Sai Life Sciences Ltd

Details

Information

Address

Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078

Phone

+9140 6815 6000

Email

investors@sailife.com

Website

Sai Life Sciences

Conclusion

Sai Life Sciences IPO represents a structured approach for investors interested in the CRDMO and pharmaceutical research industries. With its growing financials and global client base, the company showcases its market potential.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Sai Life Sciences IPO.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Frequently Asked Questions

Who is the CEO of Sai Life Sciences Ltd?

Answer Field

Kanumuri Ranga Raju is the CEO of Sai Life Sciences Ltd, leading the company with extensive experience in CRDMO and pharmaceutical services.

When will the Sai Life Sciences IPO open for subscription?

Answer Field

The Sai Life Sciences IPO opens on December 11, 2024, and closes on December 13, 2024.

What is the company’s core business, and how sustainable is its business model in the long term?

Answer Field

Sai Life Sciences specializes in CRDMO services, offering discovery, development, and manufacturing solutions to global pharma companies. Its integrated approach ensures scalability and sustainability.

What is the issue size of Sai Life Sciences IPO?

Answer Field

The issue size of Sai Life Sciences IPO is ₹3,042.62 crore, comprising ₹950 crore from a fresh issue and ₹2,092.62 crore from an offer for sale.

What is pre-apply for Sai Life Sciences IPO?

Answer Field

‘Pre-apply’ enables investors to bid for the IPO before its official opening, ensuring early participation in the subscription process.

When will I know if my Sai Life Sciences IPO order is placed?

Answer Field

Once the UPI mandate is approved, your application will be confirmed. Updates can be tracked on your trading platform or the registrar’s website.

What is the lot size and minimum order quantity of the Sai Life Sciences IPO?

Answer Field

The minimum lot size for the Sai Life Sciences IPO is 27 shares, requiring a retail investment of ₹14,823.

What is the allotment date for the Sai Life Sciences IPO?

Answer Field

The allotment for Sai Life Sciences IPO is expected to be finalized on December 16, 2024.

Who is the registrar of Sai Life Sciences IPO?

Answer Field

Kfin Technologies Limited is the registrar for the Sai Life Sciences IPO, managing allotment and refunds.

Are there any governance issues or red flags in the company’s leadership or board structure?

Answer Field

No significant governance issues or red flags have been reported regarding the leadership or board structure of Sai Life Sciences Ltd.

No Result Found

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5300+ Cr MTF Book

icon-with-text